Jason D. Merker, Ph.D.
Affiliations: | 2003 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Genetics, Cell BiologyGoogle:
"Jason Merker"Parents
Sign in to add mentor| Thomas D. Petes | grad student | 2003 | UNC Chapel Hill | |
| (Analysis of meiotic recombination initiation and subsequent patterns of heteroduplex formation in Saccharomyces cerevisiae.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen JA, Hou Y, Roskin KM, et al. (2021) Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Advances. 5: 3492-3496 |
| Zhang BM, Keegan A, Li P, et al. (2021) An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies. Archives of Pathology & Laboratory Medicine |
| Keegan A, Bridge JA, Lindeman NI, et al. (2020) Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies. Archives of Pathology & Laboratory Medicine |
| Fernandez-Pol S, Costa HA, Steiner DF, et al. (2019) High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations. Applied Immunohistochemistry & Molecular Morphology : Aimm. 27: 740-748 |
| Keung ES, Souers RJ, Bridge JA, et al. (2019) Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests. Archives of Pathology & Laboratory Medicine |
| Frésard L, Smail C, Ferraro NM, et al. (2019) Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nature Medicine |
| Moncur JT, Bartley AN, Bridge JA, et al. (2019) Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Archives of Pathology & Laboratory Medicine |
| Surrey LF, Oakley FD, Merker JD, et al. (2019) Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on BRAF, EGFR, and KRAS Proficiency Testing Samples. Archives of Pathology & Laboratory Medicine |
| Li P, Shahmarvand N, Lynch D, et al. (2019) Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist. International Journal of Laboratory Hematology |
| Kim AS, Bartley AN, Bridge JA, et al. (2019) 31. The PT alphabet soup: LDT, FDA, NGS, non-NGS, @#$!% Cancer Genetics and Cytogenetics |